Form 4: Anterix CFO Elena Marquez Receives Equity Grant

Anterix Inc. CFO Elena Marquez was granted 3,694 restricted stock units and 17,453 stock options as part of an equity compensation package.

Summary

• Elena Marquez, Chief Financial Officer of Anterix Inc., received an equity grant on May 20, 2026.
• The grant includes 3,694 restricted stock units (RSUs) and 17,453 stock options with an exercise price of $60.90.
• Both the RSUs and the stock options vest over a three-year period, with one-third vesting on May 20, 2027, and the remainder vesting quarterly through May 20, 2029.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is expected in the normal course of business.

Positives

• Equity-based compensation aligns the interests of the CFO with long-term shareholder value.
• The multi-year vesting schedule encourages executive retention.

Negatives

• The issuance of new equity results in potential dilution for existing shareholders.

Risks

• The value of the granted options is dependent on the future market performance of Anterix common stock exceeding the $60.90 strike price.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a standard disclosure of executive compensation.

Industry Context

StockSavvy.ai notes that equity grants for C-suite executives are standard practice in the technology and telecommunications sectors to ensure leadership retention and performance alignment.

Comparison to Industry Standards

• The three-year vesting schedule is consistent with standard corporate governance practices for executive compensation in the U.S. mid-cap technology sector.

Stakeholder Impact

• Shareholders may experience minor dilution from the issuance of new shares upon the vesting of these equity instruments.

Next Steps

• Vesting of equity grants beginning May 20, 2027.

Key Dates

Keywords

Anterix, ATEX, CFO, Equity Compensation, Insider Transaction, Form 4